Showing results (71-80 of 146) with videos related to
Sort By:
Pageof 15
Cancer Chemotherapy and Pharmacology|October 3, 2007
Phase I trial of PEG-interferon and recombinant IL-2 in patients with metastatic renal cell carcinomaSaby George, Thomas E Hutson, Tarek Mekhail, et al.The Journal of Urology|November 13, 2007
Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapyIla Tamaskar, Jorge A Garcia, Paul Elson, et al.Investigational New Drugs|August 17, 2010
A phase II study of tandutinib (MLN518), a selective inhibitor of type III tyrosine receptor kinases, in patients with metastatic renal cell carcinomaDale R Shepard, Matthew M Cooney, Paul Elson, et al.BJU International|September 16, 2010
Clinical and immunomodulatory effects of bevacizumab and low-dose interleukin-2 in patients with metastatic renal cell carcinoma: results from a phase II trialJorge A Garcia, Tarek Mekhail, Paul Elson, et al.Clinical Genitourinary Cancer|June 8, 2007
The prognostic significance of epidermal growth factor receptor expression in clear-cell renal cell carcinoma: a call for standardized methods for immunohistochemical evaluationDavid Cohen, Brian Lane, Tao Jin, et al.Cancer Research|April 3, 2003
Gangliosides expressed by the renal cell carcinoma cell line SK-RC-45 are involved in tumor-induced apoptosis of T cellsDaisuke Kudo, Patricia Rayman, Claudine Horton, et al.Current Pharmaceutical Design|August 13, 2002
Inhibition of NF-kappaB and proteasome activity in tumors: can we improve the therapeutic potential of topoisomerase I and topoisomerase II poisonsRam Ganapathi, Susan A J Vaziri, Masahiro Tabata, et al.Critical Reviews in Immunology|January 17, 2008
Improving immunotherapy by conditionally enhancing MHC class I presentation of tumor antigen-derived Peptide epitopesWalter J Storkus, Christopher Herrem, Mayumi Kawabe, et al.Cancer|May 20, 2008
Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinomaEric Jonasch, Walter M Stadler, Ronald M Bukowski, et al.Journal of the National Cancer Institute|January 5, 2007
Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinibBrian I Rini, Ila Tamaskar, Phillip Shaheen, et al.Pageof 15